KAYS
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
544.49K
KKPCF
Price
$28.09
Change
+$1.18 (+4.38%)
Updated
Apr 28 closing price
Capitalization
1.01B
Interact to see
Advertisement

KAYS vs KKPCF

Header iconKAYS vs KKPCF Comparison
Open Charts KAYS vs KKPCFBanner chart's image
Kaya Holdings
Price$0.01
Change-$0.00 (-0.00%)
Volume$554
Capitalization544.49K
Kaken Pharmaceutical
Price$28.09
Change+$1.18 (+4.38%)
Volume$200
Capitalization1.01B
KAYS vs KKPCF Comparison Chart in %
Loading...
KAYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KAYS vs. KKPCF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KAYS is a Hold and KKPCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (KAYS: $0.01 vs. KKPCF: $28.09)
Brand notoriety: KAYS and KKPCF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: KAYS: 2% vs. KKPCF: 100%
Market capitalization -- KAYS: $544.49K vs. KKPCF: $1.01B
KAYS [@Pharmaceuticals: Generic] is valued at $544.49K. KKPCF’s [@Pharmaceuticals: Generic] market capitalization is $1.01B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KAYS’s FA Score shows that 1 FA rating(s) are green whileKKPCF’s FA Score has 1 green FA rating(s).

  • KAYS’s FA Score: 1 green, 4 red.
  • KKPCF’s FA Score: 1 green, 4 red.
According to our system of comparison, both KAYS and KKPCF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KAYS’s TA Score shows that 4 TA indicator(s) are bullish.

  • KAYS’s TA Score: 4 bullish, 5 bearish.

Price Growth

KAYS (@Pharmaceuticals: Generic) experienced а -47.39% price change this week, while KKPCF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.10%. For the same industry, the average monthly price growth was +9.00%, and the average quarterly price growth was +87.12%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KKPCF($1.01B) has a higher market cap than KAYS($544K). KKPCF has higher P/E ratio than KAYS: KKPCF (11.30) vs KAYS (3.30). KKPCF YTD gains are higher at: 4.899 vs. KAYS (-53.214). KKPCF has higher annual earnings (EBITDA): 26B vs. KAYS (-1.68M). KKPCF has more cash in the bank: 84B vs. KAYS (50.7K). KAYS has less debt than KKPCF: KAYS (9.17M) vs KKPCF (3.85B). KKPCF has higher revenues than KAYS: KKPCF (87.2B) vs KAYS (14.2K).
KAYSKKPCFKAYS / KKPCF
Capitalization544K1.01B0%
EBITDA-1.68M26B-0%
Gain YTD-53.2144.899-1,086%
P/E Ratio3.3011.3029%
Revenue14.2K87.2B0%
Total Cash50.7K84B0%
Total Debt9.17M3.85B0%
FUNDAMENTALS RATINGS
KAYS: Fundamental Ratings
KAYS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
66
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KAYSKKPCF
RSI
ODDS (%)
Bullish Trend 4 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
11%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
11%
Advances
ODDS (%)
Bullish Trend 20 days ago
67%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
78%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KAYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOLCX16.180.08
+0.50%
DWS RREEF Global Infrastructure C
SSCGX36.910.13
+0.35%
SEI Small Cap Growth F (SIMT)
HFYRX12.940.04
+0.31%
Hartford Schroders Intl Multi-Cp Val R3
LSFLX15.00-0.05
-0.33%
Lord Abbett Focused Large Cap Value R4
SMGIX39.44-0.20
-0.50%
Columbia Contrarian Core Inst

KAYS and

Correlation & Price change

A.I.dvisor tells us that KAYS and KMDA have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KAYS and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAYS
1D Price
Change %
KAYS100%
-2.24%
KMDA - KAYS
20%
Poorly correlated
+1.13%
UPC - KAYS
5%
Poorly correlated
-4.83%
VRNOF - KAYS
3%
Poorly correlated
+5.51%
KKPCF - KAYS
2%
Poorly correlated
N/A
SHIEF - KAYS
2%
Poorly correlated
N/A
More

KKPCF and

Correlation & Price change

A.I.dvisor tells us that KKPCF and OVATF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KKPCF and OVATF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KKPCF
1D Price
Change %
KKPCF100%
N/A
OVATF - KKPCF
24%
Poorly correlated
N/A
LOVFF - KKPCF
6%
Poorly correlated
-1.09%
KAYS - KKPCF
2%
Poorly correlated
-2.24%
TRUFF - KKPCF
1%
Poorly correlated
-0.35%
GENPF - KKPCF
1%
Poorly correlated
N/A
More